Assalman Iyas, Ahmed Alia, Alhajjar Randa, Bewley Anthony P, Taylor Ruth
East London NHS Foundation Trust, London, UK.
University Hospital Lewisham, Department of Dermatology, Lewisham High Street, London, UK, SE13 6LH.
Cochrane Database Syst Rev. 2019 Dec 10;12(12):CD011326. doi: 10.1002/14651858.CD011326.pub2.
Primary delusional infestation (DI) is a primary psychiatric disorder characterised by delusions and abnormal tactile sensations. The pathophysiology is undecided and treatment includes both pharmacological and non-pharmacological options. There is currently no Cochrane Review of the treatments used. Primary DI is a diagnosis often encountered by both dermatologists and psychiatrists, with a large associated disease burden.
To evaluate the effectiveness of different treatments in primary delusional infestation (DI).
On 24 December 2014 and 19 March 2019, we searched the Cochrane Schizophrenia Group's Study-Based Register of Trials including registries of clinical trials.
Randomised controlled trials involving the treatment of adults with primary DI.
Two review authors independently screened and assessed studies for inclusion using pre-specified inclusion criteria.
We did not identify any studies for inclusion.
AUTHORS' CONCLUSIONS: Currently there is no evidence from RCTs available to compare treatment of primary DI with placebo. We cannot, therefore, make any conclusions regarding the effects of treatments (pharmacological or non-pharmacological) for primary DI. This lack of evidence for treatment of primary DI has implications for research and practice. Robust randomised trials are indicated.
原发性妄想性寄生虫感染(DI)是一种以妄想和异常触觉为特征的原发性精神障碍。其病理生理学尚未明确,治疗包括药物和非药物选择。目前尚无关于所使用治疗方法的Cochrane系统评价。原发性DI是皮肤科医生和精神科医生常遇到的诊断,伴有巨大的相关疾病负担。
评估不同治疗方法对原发性妄想性寄生虫感染(DI)的有效性。
2014年12月24日和2019年3月19日,我们检索了Cochrane精神分裂症研究组基于研究的试验注册库,包括临床试验注册库。
涉及治疗成年原发性DI患者的随机对照试验。
两位综述作者独立使用预先设定的纳入标准筛选和评估纳入研究。
我们未识别出任何纳入研究。
目前尚无随机对照试验的证据可用于比较原发性DI的治疗与安慰剂。因此,我们无法就原发性DI的治疗(药物或非药物)效果得出任何结论。原发性DI治疗缺乏证据对研究和实践均有影响。需要开展有力的随机试验。